Charles Lim Capital LTD Dr Reddys Laboratories LTD Transaction History

Charles Lim Capital LTD

  • $352 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$36.05 - $42.76 $4.41 Million - $5.23 Million
-122,398 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$35.77 - $40.57 $10.4 Million - $11.7 Million
-289,405 Reduced 70.28%
122,398 $4.96 Million
Q4 2018

Feb 14, 2019
BUY
$31.89 - $38.44 $13.1 Million - $15.8 Million
411,803 New
411,803 $15.5 Million

Others Institutions Holding RDY

# of Institutions
245
Shares Held
23.1M
Call Options Held
12.7K
Put Options Held
6.1K
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Charles Lim Capital LTD Portfolio

Follow Charles Lim Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Lim Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Charles Lim Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email